Name: Anteris Technologies Global (AVR) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

AVR

Health Care Equipment & Services

Anteris Technologies Global

Short interest: 1.97%; +1.97 pp 30d; as of 20 Aug 2026
Reported shorts: 298.2K
Shares on issue: 15.127M

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

About Anteris Technologies Global

Anteris Technologies Ltd specializes in developing advanced heart valve technologies, focusing on delivering innovative solutions to address unmet medical needs in cardiac surgery. Positioned as a frontrunner in the heart valve market, Anteris leverages its proprietary ADAPT tissue technology and DurAVR 3D single-piece aortic heart valves to enhance patient outcomes. The company's unique value lies in its commitment to revolutionizing cardiovascular care with cutting-edge scientific research and development.

Company profile →

Anteris Technologies Global (ASX:AVR) has 1.97% of its shares on issue reported as short positions as of 20 Aug 2026, or about 298,228 shares. Over the past 30 days that figure has risen 1.97 percentage points, and over 90 days it has risen 1.97 percentage points. AVR is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Short interest

History & FAQ →

Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.

Strategy fit

How each stock picker strategy reads AVR today

Zanger BreakoutNot a candidate
CAN SLIMWatchScore 15rank 889 of 1541
Minervini Trend TemplateWatchScore 33rank 490 of 1716
Crowded-Short BreakoutWatchScore 15rank 590 of 1500
Quality compoundersNot a candidate

Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →

AVR fundamentals

In the year to 31 Dec 2025, Anteris Technologies Global (ASX:AVR) recorded revenue of US$1.9M and a net loss after tax of US$94.1M. A year earlier it recorded revenue of US$2.7M and a net loss after tax of US$76.3M. Year-on-year growth: revenue −29.2% (FY). Net margin −4,921.3% (FY). Figures are in USD, the company's reporting currency; source: ASX (Markit), as at 14 Oct 2026.

Full statements, ratios and filings are on the Financials tab. Not financial advice.

Full financials →